Immune checkpoint inhibitors are superior to docetaxel as second-line therapy for patients with non-small cell lung carcinoma
-
Published:2018-03-25
Issue:3
Volume:68
Page:178-179
-
ISSN:0007-9235
-
Container-title:CA: A Cancer Journal for Clinicians
-
language:en
-
Short-container-title:CA: A Cancer Journal for Clinicians
Subject
Oncology,Hematology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献